Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
The goal of this proposal is to describe, compare, and explain variations in Lynch syndrome (LS) screening implementation across multiple healthcare systems and create a comprehensive, customizable organizational toolkit for implementing LS screening.
PI is Alanna K. Rahm, PhD, MS, LGC, Geisinger Medicine Institute. Site PI is Su-Ying Liang, Ph.D.
Collaborating sites include the following:
Andrea N. Burnett-Hartmann, Ph.D., MPH, Kaiser Permanente Colorado; Mara Epstein, Sc.D., Meyers Primary Care; Jessica Enzell Hunter, Ph.D., Kaiser Permanente Northwest; Christine Y. Lu, Ph.D., Harvard Pilgrim Health Care Institute; Pamala Palowski, Pharm.D., Health Partners; Ravi Sharaf, M.D., Northwell Health; and Robert Weil, M.D., Catholic Health Initiatives.
External PI, Principal Investigator, Su-Ying Liang, Ph.D.
National Cancer Institute
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Risk-Benefit Trade-Offs for Whole Genome Sequencing
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D.